Microfluidic Channel for Cell Transduction Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for cell culture and transduction using viral vectors are inefficient due to diffusion limitations, leading to significant decay of viral particles before they reach cells, requiring high quantities that are costly and potentially toxic.

Innovation Solution

A device with a continuous channel configuration, including a transduction region, connection region, and flushing region, designed to increase contact between viral vectors and target cells, allowing for efficient transduction by minimizing vector waste and reducing transduction times.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If greater quantities of viral vectors are used to overcome diffusion limitations, then transduction efficiency is improved, but cost increases and cell toxicity increases

Engineering Contradiction:
Improvetransduction efficiencyVSAvoidamount of viral vectors
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The device segments the transduction process into distinct functional regions (loading region, transduction region, flushing region) within a microfluidic channel, allowing controlled interaction between viral vectors and target cells in the transduction region while separating waste removal functions. This segmentation enables efficient transduction with lower viral vector quantities by concentrating the interaction space.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention transitions from conventional two-dimensional transduction surfaces to a three-dimensional microfluidic environment where target cells are suspended and circulated through the transduction region. This dimensional change increases the contact probability between viral vectors and cells, improving transduction efficiency without requiring proportional increases in viral vector quantity.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Productivity

If greater quantities of viral vectors are used to overcome diffusion limitations, then transduction efficiency is improved, but cost increases

Engineering Contradiction:
Improvetransduction efficiencyVSAvoidproduction cost
Core Design Contradiction:
ProductivityVSEase of manufacture

Solution Approach 1:

The device segments the transduction process into distinct functional regions (loading region, transduction region, flushing region) within a microfluidic channel, allowing controlled interaction between viral vectors and target cells in the transduction region while separating waste removal functions. This segmentation enables efficient transduction with lower viral vector quantities by concentrating the interaction space.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention changes key parameters of the transduction environment including flow rate, residence time, and cell concentration within the microfluidic channel. By optimizing these parameters, the system achieves high transduction efficiency with reduced viral vector requirements, thereby lowering production costs associated with viral vector manufacturing.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If greater quantities of viral vectors are used to overcome diffusion limitations, then transduction efficiency is improved, but cell toxicity increases

Engineering Contradiction:
Improvetransduction efficiencyVSAvoidcell toxicity
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The device segments the transduction process into distinct functional regions (loading region, transduction region, flushing region) within a microfluidic channel, allowing controlled interaction between viral vectors and target cells in the transduction region while separating waste removal functions. This segmentation enables efficient transduction with lower viral vector quantities by concentrating the interaction space.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The microfluidic system maintains continuous flow and circulation of target cells through the transduction region, ensuring sustained exposure to viral vectors without stagnation. This continuous action improves transduction efficiency while using lower viral vector quantities, thereby reducing cell toxicity associated with high concentrations of viral vectors.

Inventive Principle:
Principle #20Continuity of useful action

4Ease of operation

If conventional transduction methods are used, then simplicity is maintained, but transduction efficiency is reduced due to diffusion limitations

Engineering Contradiction:
Improveoperational simplicityVSAvoidtransduction efficiency
Core Design Contradiction:
Ease of operationVSProductivity

Solution Approach 1:

The device employs microfluidic hydraulic flow to transport and mix target cells with viral vectors in the transduction region. This hydraulic approach replaces passive diffusion with active fluid-driven transport, significantly improving transduction efficiency while maintaining automated operation that preserves ease of use.

Inventive Principle:
Principle #29Pneumatics and hydraulics

Solution Approach 2:

The invention changes key parameters of the transduction environment including flow rate, residence time, and cell concentration within the microfluidic channel. By optimizing these parameters, the system achieves high transduction efficiency with reduced viral vector requirements, thereby lowering production costs associated with viral vector manufacturing.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS20250101462A1Methods, Devices and Systems for Enhanced Transduction Efficiency
Publication Date: 2025.03.27 GEORGIA TECH RES CORP
  • US20250101462A1 patent drawing
  • US20250101462A1 patent drawing
  • US20250101462A1 patent drawing

AI summary

The systems and methods are directed to leveraging the channel geometry and configuration to overcome diffusion limitations of current transduction systems. The methods may include a method of transducing target cells using a device. The device may include at least one continuous channel. The method may include delivering target cells and viral vectors into a transduction region of the channel. After transducing for some incubation time, a flushing solution may be delivered. The method may include collecting transduced cells after the transducing incubation time and the delivering of the flushing solution.